国家神经系统疾病临床医学研究中心数据管理与共享系统
Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Implementation and Outcome of Thrombolysis with Alteplase 3 to 4.5 h After Acute Stroke in Chinese Patients
第一作者：Xiaoling Liao,Chunxue Wang
通讯作者：Yongjun Wang
基本信息
- 负责人：Xiaoling Liao,Chunxue Wang
- 数据来源： TIMS-CHINA
- 论文编号：TIMS-CHINA20150128
- 发表时间：2013-01-10
2013-01-10
已发表文章
发表杂志：CNS Neuroscience & Therapeutics
发表类型: Original Contributions
影响因子(IF): 5.243
PMID: 23206165 Pubmed原文链接 全文下载
主要研究背景及目的
The European Cooperative Acute Stroke Study (ECASS) III showed that intravenous recombinant tissue plasminogen activator (rtPA) administered in the 3 to 4.5 h after symptom onset significantly improved clinical outcomes in patients with acute ischemic stroke (AIS). But little is known regarding the safety and efficacy of intravenous rtPA treatment within this extended time window in Chinese patients with AIS.